Endo International plc (NASDAQ: ENDP) today announced the publication of Phase 2 data evaluating collagenase clostridium histolyticum (or "CCH") ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE